Gharagozli K - Search Results

1

Mitochondrial D-loop variation in Persian multiple sclerosis patients: K and A haplogroups as a risk factor!!

Hassani-Kumleh H, Houshmand M, Panahi MS, Riazi GH, Sanati MH, Gharagozli K, Ghabaee M. Hassani-Kumleh H, et al. Among authors: gharagozli k. Cell Mol Neurobiol. 2006 Mar;26(2):119-25. doi: 10.1007/s10571-006-9026-z. Epub 2006 May 6. Cell Mol Neurobiol. 2006. PMID: 16763779

2

The burden of Parkinson's disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019.

Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Singh K, Kolahi AA, Gharagozli K. Safiri S, et al. Among authors: gharagozli k. BMC Public Health. 2023 Jan 16;23(1):107. doi: 10.1186/s12889-023-15018-x. BMC Public Health. 2023. PMID: 36642724 Free PMC article.

3

Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?

Fesahat F, Houshmand M, Panahi MS, Gharagozli K, Mirzajani F. Fesahat F, et al. Among authors: gharagozli k. Cell Mol Neurobiol. 2007 May;27(3):329-34. doi: 10.1007/s10571-006-9126-9. Epub 2006 Dec 21. Cell Mol Neurobiol. 2007. PMID: 17186363

4

Association of rs12487066, rs12044852, rs10735781, rs3135388, rs6897932, rs1321172, rs10492972, and rs9657904 Polymorphisms with Multiple Sclerosis in Iranian Population.

Razavian T, Shakib ME, Gharagozli K, Maghsoudi H, Bidoki SK, Sadeghi S, Houshmand M. Razavian T, et al. Among authors: gharagozli k. Oman Med J. 2020 Jul 20;35(4):e150. doi: 10.5001/omj.2020.69. eCollection 2020 Jul. Oman Med J. 2020. PMID: 32760600 Free PMC article.

5

Multiple sclerosis: report on 200 cases from Iran.

Kalanie H, Gharagozli K, Kalanie AR. Kalanie H, et al. Among authors: gharagozli k. Mult Scler. 2003 Feb;9(1):36-8. doi: 10.1191/1352458503ms887oa. Mult Scler. 2003. PMID: 12617266

6

Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments.

Mahmoudian E, Khalilnezhad A, Gharagozli K, Amani D. Mahmoudian E, et al. Among authors: gharagozli k. Gene. 2017 Nov 15;634:29-36. doi: 10.1016/j.gene.2017.08.021. Epub 2017 Aug 24. Gene. 2017. PMID: 28844667

7

Interferon Beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran.

Kalanie H, Gharagozli K, Hemmatie A, Ghorbanie M, Kalanie AR. Kalanie H, et al. Among authors: gharagozli k. Eur Neurol. 2004;52(4):202-6. doi: 10.1159/000082036. Epub 2004 Nov 10. Eur Neurol. 2004. PMID: 15539773 Clinical Trial.

8

Myasthenia gravis development and crisis subsequent to multiple sclerosis.

Gharagozli K, Shojaei M, Harandi AA, Akbari N, Ilkhani M. Gharagozli K, et al. Case Rep Med. 2011;2011:291731. doi: 10.1155/2011/291731. Epub 2011 May 18. Case Rep Med. 2011. PMID: 21629802 Free PMC article.

9

Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.

Gharagozli K, Poorsaadat L, Harandi AA, Pakdaman H, Kalanie H. Gharagozli K, et al. Iran J Neurol. 2012;11(3):118-20. Iran J Neurol. 2012. PMID: 24250877 Free PMC article.

10

Old findings in multiple sclerosis but a new application.

Harandi AA, Sahraiyan MA, Gharagozli K, Pakdaman H, Kalanie H. Harandi AA, et al. Among authors: gharagozli k. Clin Neurol Neurosurg. 2012 May;114(4):411. doi: 10.1016/j.clineuro.2011.11.014. Epub 2011 Nov 30. Clin Neurol Neurosurg. 2012. PMID: 22134103 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters